In 2014, new combination therapies to treat patients with metastatic melanoma hit the market, helping extend the lives of those with this aggressive disease. Yet unfortunately, after several months of treatment, almost all patients on the regimen...
Original Article: Melanoma cells rewire to resist drug treatment
NEXT ARTICLE